MarketsStocksVIVIMEDLAB
VI

Vivimed Labs Ltd

NSE: VIVIMEDLABBSE: 532660Healthcare
Download Research Report7-page PDF
6.18
-4.92%
NSE · auto-updates while market open
Prev Close
₹4.95
Day High
₹6.54
Day Low
₹6.08
Mkt Cap
₹53 Cr
P / E
-
P / B
-
ROE
-
52W High
₹29.40
52W Low
₹4.95
Key Metrics
Market Cap
₹53 Cr
P / E
-
P / B
-
EV / EBITDA
62.99
ROCE
-8.8%
ROE
-
Debt / Equity
-
Book Value
-
EPS
-
Div Yield
0.0%
Face Value
₹2
Promoter Holding
7.6%
Revenue · ₹ Cr
1.3k
FY19
1.1k
FY20
861
FY21
237
FY22
187
FY23
149
FY24
116
FY25
Net Profit · ₹ Cr
115
0
-109
-78
-68
-329
-45
FY19FY20FY21FY22FY23FY24FY25
EPS · ₹ per share
₹5.0
₹7.0
₹-13.2
₹-18.8
₹-8.2
₹-39.6
₹-5.5
FY16FY19FY20FY21FY22FY23FY24
P / E Ratio · price ÷ TTM EPS
5-180-41Jun 21Feb 23Oct 24Jun 26
TTM EPS
Q4 2025 snapshot
Sales
₹16 Cr
Operating profit
-
OPM
-
Net profit
₹-17 Cr
EPS
₹-0.88
Scorecard · 7 axes
Quality
Bad
27/100
Valuation
-
Growth
Bad
-25.6%
Profitability
Bad
-4.4%
Performance
Good
+31.3%
Entry Point
Strong
21%
Red Flags
Strong
0 flags
Shareholding Pattern
7.6%Promoter
Promoter7.6%
FII1.6%
Public90.8%
Quarterly Results · ₹ Cr
QuarterFY24 09QFY24 12QFY25 03QFY25 06QFY25 09QFY25 12Q
Revenue24.77236.5129.8321.7720.8215.99
Net Profit-5.141-5.975-5.137-5.493-7.302-16.554
NPM %-20.8%-16.4%-17.2%-25.2%-35.1%-103.5%
AlertPre-trade